Coptidis rhizoma and berberine as anti-cancer drugs: A 10-year updates and future perspectives

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.1016/j.phrs.2025.107742

Coptidis rhizoma and berberine as anti-cancer drugs: A 10-year updates and future perspectives

· 2025-04-19

14Citations

Links

DOI PubMed

TL;DR

An exhaustive overview of the cancer-fighting characteristics of Coptidis Rhizoma and berberine is offered, while also exploring recent developments in nanotechnology aimed at enhancing the bioavailability of berberine.

AI-generated by Semantic Scholar

Funding

Health and Medical Research Fund Grant 204610519 Health and Medical Research Fund Grant 16172751 Health and Medical Research Fund Grant 21222101 Health and Medical Research Fund Grant 15162961 Health and Medical Research Fund Grant 202007002 Health and Medical Research Fund Grant 18192141 Gaia Family Trust, New Zealand Grant 200007008